Induction immunosuppression strategy and outcomes in contemporary adult liver transplantation: a national cohort analysis
Authors:
- Sohail KhanSKSohail Khan
- Isabella FariaIFIsabella Faria
- Deric ToroDTDeric Toro
- Olzhas ZhorayevOZOlzhas Zhorayev
- Sidhartha D. RaySRSidhartha D. Ray
- Gavin McAfeeGMGavin McAfee
- Dayanna ZuluagaDZDayanna Zuluaga
- Michael FotiMFMichael Foti
- Mary Ellen DeanMDMary Ellen Dean
- Meng-Hao LiMLMeng-Hao Li
- Naoru KoizumiNKNaoru Koizumi
- Tanner JonesTJTanner Jones
- 19 November 2026
- journal article
- Published by Elsevier in Transplant Immunology
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The evolving immunotherapy-associated toxicities in clinical medicine2025
- The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipientsAmerican Journal of Transplantation, 2023
- Immunosuppressive Drugs in Liver Transplant: An InsightJournal of Clinical and Experimental Hepatology, 2022
- Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparatorsPharmacoepidemiology and Drug Safety, 2022
- Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the “Net State of Immunosuppression”Clinical Infectious Diseases, 2020
- Comparison of Clinical Outcomes of Induction Regimens in Patients Undergoing Liver Transplantation for Acute Liver FailureLiver Transplantation, 2020
- Immunosuppression in Donation After Circulatory Death Liver Transplantation: Can Induction Modify Graft Survival?Liver Transplantation, 2020
- Immunosuppression in liver transplantBest Practice & Research Clinical Gastroenterology, 2020
- The immunology of organ transplantationSurgery (Oxford), 2017
- Interleukin 2 receptor antagonists for liver transplant recipients: A systematic review and meta-analysis of controlled studiesHepatology, 2011